Systemic lupus erythematosus (SLE) is a complex autoimmune disease that remains challenging to diagnose and treat. In this interview, rheumatologist and clinical epidemiologist Zahi Touma, Associate Professor of Medicine, Clinician Scientist, University of Toronto, Canada, highlights the need for a shift from traditional symptom suppression to early and proactive treat-to-target approaches.
In this issue
Rate this content's potential impact on patient outcomes
Average rating / 5. Vote count:
No votes so far! Be the first to rate this content.
Latest articles
All articles


